162
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Molecular surveillance of chloroquine drug resistance markers (Pfcrt and Pfmdr1) among imported Plasmodium falciparum malaria in Qatar

, ORCID Icon, , , , , , , , , & show all

References

  • World Malaria Report. World Health Organization. Geneva; 2016 Available from: http://www.who.int/malaria/publications/world-malaria-report-2016/report/en/
  • WHO; 2004. Available from: http://www.who.int/csr/resources/publications/drugresist/malaria.pdf
  • Shah NK, Dhillon GP, Dash AP, et al. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis. 2011;11:57–64.
  • Verlinden BK, Louw A, Birkholtz LM. Resisting resistance: is there a solution for malaria? Expert Opin Drug Discov. 2016;11:395–406.
  • Dorsey G, Vlahos J, Kamya MR, et al. Prevention of increasing rates of treatment failure by combining sulfadoxine‐pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J Infect Dis. 2003;188:1231–1238.
  • Djimdé A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257–263.
  • Beljaev AE. The malaria situation in the WHO Eastern Mediterranean Region. Med Parazitol (Mosk). 2000;2:12–15.
  • Al-Kuwari MG. Epidemiology of imported malaria in Qatar. J Travel Med. 2009;16:119–122.
  • Mikhail MW, Al-Bursheed KM, Abd El-Halim AS, et al. Studies on mosquito borne diseases in Egypt and Qatar. J Egypt Soc Parasitol. 2009;39:745–756.
  • Khan FY, Elshafie SS, Almaslamani M, et al. Epidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study. Travel Med Infect Dis. 2010;8:377–387.
  • World Malaria Report. World Health Organization. Geneva; 2014 Available from: http://www.emro.who.int/annual-report/2014/table-2-parasitologically-confirmed-cases-in-countries-with-no-or-sporadic-transmission-and-countries-with-low-malaria-endemicity.html
  • Tatem AJ, Jia P, Ordanovich D, et al. The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics. Lancet Infect Dis. 2017;17:98–107.
  • Singh GB, Bobogare A, Cox-Singh J, et al. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999;60:687–692.
  • Duraisingh MT, Von Seidlein LV, Jepson A, et al. Linkage disequilibrium between two chromosomally distinct loci associated with increased resistance to chloroquine in Plasmodium falciparum. Parasitology. 2000;121:1–7.
  • Jelinek AT, Aida SAO, Peyerl-Hoffmann TG, et al. Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania. Am J Trop Med Hyg. 2002;67:449–453.
  • Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94:181–190.
  • Kublin JG, Cortese JF, Njunju EM, et al. Re-emergence of chloroquine- sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870–1875.
  • Mockenhaupt FP, Ehrhardt S, Eggelte TA, et al. Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. Ann Trop Med Parasitol. 2005;99:723–732.
  • Mula P, Fernández-Martínez A, de Lucio A, et al. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia. Malar J. 2011;10:214.
  • Kebede F, Taffa N, Tedla T. An in vivo study of falciparum malaria sensitivity to chloroquine in unstable malaria endemic areas of central Ethiopia. Ethiop Med J. 1999;37:97–109.
  • Chatterjee M, Ganguly S, Saha P, et al. Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India. Infect Genet Evol. 2016;44:281–285.
  • Khattak AA, Venkatesan M, Jacob CG, et al. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan. Malar J. 2013;12:300.
  • Frosch AE, Venkatesan M, Laufer MK. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malar J. 2011;10:116.
  • Frosch AE, Laufer MK, Mathanga DP, et al. Return of widespread chloroquine-sensitive plasmodium falciparum to Malawi. J Infect Dis. 2014;1(210):1110–1114.
  • Mwai L, Ochong E, Abdirahman A, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8:106.
  • Ndiaye M, Faye B, Tine R, et al. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal. Am J Trop Med Hyg. 2012;87:640–645.
  • Dorsey G, Kamya MR, Singh A, et al. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr‐1 Genes and Clinical Response to Chloroquine in Kampala, Uganda. J Infect Dis. 2001;183:1417–1420.
  • Omar SA, Adagu IS, Gump DW, et al. Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann Trop Med Parasitol. 2001;95:661–669.
  • Djimde AA, Doumbo OK, Traore O, et al. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg. 2003;69:558–563.
  • Khalil IF, Alifrangis M, Tarimo DS, et al. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann Trop Med Parasitol. 2005;99:441–448.
  • Francis D, Nsobya SL, Talisuna A, et al. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis. 2006;193:978–986.
  • Al-Mekhlafi AM, Mahdy MA, Al-Mekhlafi HM, et al. High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy. Parasit Vectors. 2011;4:94.
  • May J, Meyer CG. Association of Plasmodium falciparum chloroquine resistance transporter variant t76 with age-related plasma chloroquine levels. Am J Trop Med Hyg. 2003;68:143–146.
  • Happi CT, Gbotosho GO, Folarin OA, et al. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and Plasmodium falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in Plasmodium falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg. 2006;75:155–161.
  • Giha HA, Elbashir MI, A-Elbasit IE, et al. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop. 2006;97:181–187.
  • Mayengue P, Kalmbach Y, Issifou S, et al. No variation in the prevalence of point mutations in the pfcrt and pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. Parasitol Res. 2007;100:487–493.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.